Switching from baricitinib to dupilumab as an advanced-line treatment in pediatric patients with atopic dermatitis: a retrospective cohort study

Ayelet Ollech, Eran Cohen-Barak, Amir Horev, Efrat Bar-Ilan, Shoshana Greenberger

    Research output: Contribution to journalLetterpeer-review

    1 Scopus citations
    Original languageEnglish
    Pages (from-to)e130-e132
    JournalInternational Journal of Dermatology
    Volume63
    Issue number7
    DOIs
    StatePublished - 1 Jul 2024

    Keywords

    • JAK inhibitors
    • atopic dermatitis
    • biological treatment
    • dupilumab baricitinib
    • pediatric patients
    • systemic treatment

    ASJC Scopus subject areas

    • Dermatology

    Cite this